Premium
Inhibition of RhoA‐mediated SRF activation by p116 Rip
Author(s) -
Mulder Jacqueline,
Ariaens Aafke,
van Horck Francis P.G.,
Moolenaar Wouter H.
Publication year - 2005
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2005.09.083
Subject(s) - rhoa , serum response factor , microbiology and biotechnology , myosin , cytoskeleton , actin , phosphatase , phosphorylation , transcription factor , chemistry , biology , biochemistry , signal transduction , cell , gene
p116 Rip , originally identified as a binding partner of activated RhoA, is an actin‐binding protein that interacts with the regulatory myosin‐binding subunit (MBS) of myosin‐II phosphatase and is essential for Rho‐regulated cytoskeletal contractility. Here, we have examined the role of p116 Rip in RhoA‐mediated activation of the transcription factor SRF. We show that p116 Rip oligomerizes via its C‐terminal coiled‐coil domain and, when overexpressed, inhibits RhoA‐induced SRF activation without affecting RhoA‐GTP levels. Mutant forms of p116 Rip that fail to oligomerize or bind to MBS are still capable of inhibiting SRF activity. Our results suggest that p116 Rip interferes with RhoA‐mediated transcription through its ability to disassemble the actomyosin cytoskeleton downstream of RhoA.